Elsie J Wang1, Eric C Wong1, Anjali A Dixit2, Stephen P Fortmann3, Randolph B Linde4, Latha P Palaniappan5. 1. Palo Alto Medical Foundation Research Institute, Department of Health Policy Research, Palo Alto, CA, United States. 2. Columbia University, Mailman School of Public Health, United States. 3. Kaiser Permanente Center for Health Research, United States. 4. Palo Alto Medical Foundation, Palo Alto, CA, United States. 5. Palo Alto Medical Foundation Research Institute, Department of Health Policy Research, Palo Alto, CA, United States. Electronic address: lathap@pamfri.org.
Abstract
AIMS: We compared the prevalence and treatment of type 2 diabetes across Asian American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese) and Non-Hispanic Whites (NHWs) in a Northern California healthcare system. METHODS: A three-year, cross-sectional sample of patient electronic health records was accessed to compare diabetes prevalence in 21,816 Asian and 73,728 NHWs aged 35+ years. Diabetes was classified through ICD-9 codes, abnormal laboratory values, or use of oral anti-diabetic medication. Multivariate adjusted prevalence rates for each Asian subgroup, and adjusted odds ratios (OR) relative to NHWs, were compared. RESULTS: Age-adjusted prevalence ranged from 5.8% to 18.2% (women) and 8.1 to 25.3% (men). Age-adjusted ORs of Asian subgroups ranged 1.11-3.94 (women) and 1.14-4.56 (men). The odds of diabetes were significantly higher in Asian Indians (women OR 3.44, men OR 3.54) and Filipinos (women OR 3.94, men OR 4.56), compared to NHWs. Results for Asian Indians and Filipinos were similar with age-and-BMI adjustment. Treatment rates across subgroups were 59.7-82.0% (women) and 62.9-79.4% (men). CONCLUSIONS: Heterogeneity exists in the prevalence of diabetes across Asian subgroups, independent of obesity prevalence. Asian Indian and Filipino subgroups had particularly high prevalence of diabetes when compared to NHWs. Future studies should explore these clinically important differences among Asian subgroups.
AIMS: We compared the prevalence and treatment of type 2 diabetes across Asian American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese) and Non-Hispanic Whites (NHWs) in a Northern California healthcare system. METHODS: A three-year, cross-sectional sample of patient electronic health records was accessed to compare diabetes prevalence in 21,816 Asian and 73,728 NHWs aged 35+ years. Diabetes was classified through ICD-9 codes, abnormal laboratory values, or use of oral anti-diabetic medication. Multivariate adjusted prevalence rates for each Asian subgroup, and adjusted odds ratios (OR) relative to NHWs, were compared. RESULTS: Age-adjusted prevalence ranged from 5.8% to 18.2% (women) and 8.1 to 25.3% (men). Age-adjusted ORs of Asian subgroups ranged 1.11-3.94 (women) and 1.14-4.56 (men). The odds of diabetes were significantly higher in Asian Indians (women OR 3.44, men OR 3.54) and Filipinos (women OR 3.94, men OR 4.56), compared to NHWs. Results for Asian Indians and Filipinos were similar with age-and-BMI adjustment. Treatment rates across subgroups were 59.7-82.0% (women) and 62.9-79.4% (men). CONCLUSIONS: Heterogeneity exists in the prevalence of diabetes across Asian subgroups, independent of obesity prevalence. Asian Indian and Filipino subgroups had particularly high prevalence of diabetes when compared to NHWs. Future studies should explore these clinically important differences among Asian subgroups.
Authors: Ronit Katz; Nathan D Wong; Richard Kronmal; Junichiro Takasu; David M Shavelle; Jeffrey L Probstfield; Alain G Bertoni; Matthew J Budoff; Kevin D O'Brien Journal: Circulation Date: 2006-04-24 Impact factor: 29.690
Authors: Swapnil N Rajpathak; Leena S Gupta; Elizabeth Needham Waddell; Ushma D Upadhyay; Rachel P Wildman; Robert Kaplan; Sylvia Wassertheil-Smoller; Judith Wylie-Rosett Journal: Ethn Dis Date: 2010 Impact factor: 1.847
Authors: Iris Shai; Rui Jiang; Joann E Manson; Meir J Stampfer; Walter C Willett; Graham A Colditz; Frank B Hu Journal: Diabetes Care Date: 2006-07 Impact factor: 19.112
Authors: Marjorie K Mau; Joseph Keawe'aimoku Kaholokula; Margaret R West; Anne Leake; James T Efird; Charles Rose; Donna-Marie Palakiko; Sheryl Yoshimura; Puni B Kekauoha; Henry Gomes Journal: Prog Community Health Partnersh Date: 2010
Authors: Latha P Palaniappan; Eric C Wong; Jessica J Shin; Maria R Moreno; Regina Otero-Sabogal Journal: Health Serv Res Date: 2009-06-22 Impact factor: 3.402
Authors: Elizabeth R Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimer Dis Assoc Disord Date: 2017 Jul-Sep Impact factor: 2.703
Authors: Samantha E Montag; Kristen L Knutson; Phyllis C Zee; Jeffrey J Goldberger; Jason Ng; Kwang-Youn A Kim; Mercedes R Carnethon Journal: Sleep Health Date: 2017-02-10
Authors: Sarah E Choi; Michael Liu; Latha P Palaniappan; Elsie J Wang; Nathan D Wong Journal: J Diabetes Complications Date: 2013-06-04 Impact factor: 2.852
Authors: Ariel T Holland; Beinan Zhao; Eric C Wong; Sarah E Choi; Nathan D Wong; Latha P Palaniappan Journal: J Diabetes Complications Date: 2012-10-11 Impact factor: 2.852